cilazapril, anhydrous has been researched along with Arterial Occlusive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asmar, R; Bauthier, P; Becquemont, L; Billaud, E; Cohen, N; Houri, L; Hugue, C; Laloux, B; Laurent, S; Vayssairat, M | 1 |
| Berger, PB; Faxon, DP; Holmes, DR; Murphy, JG; O'Hanesian, MA; Ohman, EM; Schwartz, RS; Serruys, PW | 1 |
2 trial(s) available for cilazapril, anhydrous and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Hemodynamic effects of chronic treatment by cilazapril in normotensive patients with obliterative arterial diseases of the lower limbs].
Topics: Adult; Aged; Arterial Occlusive Diseases; Cilazapril; Compliance; Female; Hemodynamics; Humans; Male; Middle Aged; Treatment Outcome | 1994 |
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Cilazapril; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Statistics, Nonparametric; Treatment Outcome | 1996 |